If you are wondering whether Alnylam Pharmaceuticals at around US$369.96 is still a compelling opportunity or already pricing ...
Get the live share price of Alnylam Pharmaceuticals Inc (ALNY), including intraday charts, historical performance, key ...
The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback